The 40-year-old comedian's shocking diagnosis

Comedian Matt Forde, host of the popular BBC Radio 4 show The Matt Forde Focus Group, was diagnosed with a rare spinal tumour and chordoma at the age of 40. the slow-growing type of bone cancer affects only eight in a million people in the UK.

Forde had been experiencing severe pain after a exercise bike session in June 2023, initially attributing it to a twisted hamstring or sciatica. However, months of investigations led to the discovery of the spinal tumour.

A 13-hour operation and a long road to recovery

Forde underwent a 13-hour operation at the Royal National Orthopaedic Hospital, followed by a lengthy recovery that left him with lasting damage, including a colostomy bag, a stoma, and chronic nerve pain. he has since adopted daily painkillers such as gabapentin to manage his symptoms.

Despite the challenges,Forde remains determined to make a full recovery and return to his normal life. He is preparing to return to the Edinburgh Fringe, where he will perform his stand-up show Project Holy Moly and record his podcast, The Political Party.

From pain to performance: Forde's resilience

Forde's determination to overcome his health challenges is inspiring. He has taken his health into his hands and is working towards a full recovery.. His positive developments, including the transformation of his eczema, are a testament to his strength and resilience.

The comedian's experience serves as a reminder of the importance of seeking medical attention and the impact of chronic pain on daily life.. Forde's story is a beacon of hope for those facing similar challenges.

Chordoma: a rare and slow-growing cancer

Chordoma is a rare type of bone cancer that affects only eight in a million people in the UK. It is a slow-growing cancer that can cause severe pain and lasting damage. forde's experience highlights the importance of awareness and early diagnosis.

The comedian's story is a reminder of the need for continued research and support for those affected by chordoma and other rare cancers.